外企在中国持续推动本土化有两个大前提:一是对中国的投资力度进一步加大;而是创新的产品要“有利可图”。 跨国医疗公司在中国的业务架构调整仍在持续。近日,强生中国包括外科在内的事业部架构发生调整,紧接着传出裁员消息。 第一财经记者从强生中国相关人士处了解到,强生新一轮的裁员自上周开启,波及公司的多个业务单元。 另一位强生前员工对第一财经记者表示:“陆陆续续一直在裁,只是未对外公告。”他还称...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.